HOT NEWS

Industry News

Tuesday, 15 April 2014   
Positive trial data suggests Exenatide has the potential to be a disease modifying agent in Parkinson's disease
The Cure Parkinson's Trust, a charity founded by four people with Parkinson's disease, which is dedicated to facilitating and funding work towards a cure, today announces the publication of trial results which suggest possible disease modifying advantages twelve months after cessation of exposure to Exenatide in patients with Parkinson's disease. Exenatide has previously been identified as having a positive impact on insulin resistance. In a Parkinson's study published in May 2013, significant and clinically meaningful differences were demonstrated between the scores for those receiving Exenatide and the controls for both motor and cognitive symptoms 12 months after the start of the trial. Both the original and the follow-up trials were conducted at the UCL Institute of Neurology and were funded by The Cure Parkinson's Trust.
 
Thursday, 10 April 2014   
Novartis announces that the XOVA (eXcellence in Ophthalmology Vision Award) is now open for entries
NovartisNovartis, the global leader in eye care, is calling for the eXcellence in Ophthalmology Vision Award (XOVA), co-sponsored by Alcon and Novartis Pharmaceuticals. The XOVA, launched in 2010, provides funding to projects worldwide that support initiatives that help deliver sustained improvements in eye care globally. It is open to all eye care specialists, including trainees and specialist nurses and grant funding will be provided to the employing institution of the winning applicant.
 
Tuesday, 08 April 2014   
Unexpected results in cancer drug trial
Research from the University of Southampton has shown a drug, used in combination with chemotherapy to treat advanced colorectal cancer, is not effective in some settings, and indeed may result in more rapid cancer progression.The New EPOC study, published in The Lancet Oncology and funded by Cancer Research UK, evaluated whether the drug cetuximab and chemotherapy together worked better than chemotherapy alone as a treatment in addition to surgery for people with bowel cancer that had spread to the liver but could be surgically removed. In the trial patients either received chemotherapy on its own or chemotherapy combined with cetuximab.
 

Research & Development

Positive trial data suggests Exenatide has the potential to be a disease modifying agent in Parkinson's disease

The Cure Parkinson's Trust, a charity founded by four people with Parkinson's disease, which is dedicated to facilitating and funding...

Unexpected results in cancer drug trial

Research from the University of Southampton has shown a drug, used in combination with chemotherapy to treat advanced colorectal cancer,...

Novel plant biotechnology approach for sustainable production of pharmaceutical compounds

European scientists have made ground-breaking discoveries for improving the efficiency of the production of pharmaceuticals through plant biotechnology. Biotechnological production...

Choices in TB vaccine development

Scarce global funding for the development of new tuberculosis vaccines forces to select rigorously in the current portfolio of TB...

More in: Research & Development

Conferences & Events

Delegates from more than 30 countries to share the benefits of eHealth at WoHIT 2014

2 - 4 April 2014, Nice, France. The World of Health IT Conference and Exhibition 2014 (WoHIT 2014), taking place in Nice, France, presents a comprehensive international programme with 18...

HIMSS Europe Online Matchmaking at WoHIT 2014

2 - 4 April 2014, Nice, France. The World of Health IT 2014 (WoHIT 2014) will combine the following global audiences: influential European C-Suites, Nordic countries looking to invest, non-European...

Doctors 2.0 & You to address the "explosion of digital health tools" with new subjects, speakers, partners

5 - 6 June 2014, Paris, France. Doctors 2.0 & You, partner of Stanford Medicine X and known for its 360° inclusive perspective on the patient, the physician, and digital...

eHealth Forum 2014

12 - 14 May 2014, Athens, Greece. Organised by the Greek Presidency of the Council of the European Union in cooperation with the European Commission, the eHealth Forum 2014 brings...

mHealth Summit Europe 2014 Call for Papers

6 - 8 May 2014, Berlin, Germany. mHealth Summit Europe brings together global leaders in government, the private sector, industry, academia, providers and not-for-profit organizations from across the mHealth ecosystem....

More in: Conferences & Events

EC Pharmaceuticals

Medicines for children: more research, more availability and more information compared with 5 years ago

News image

Recently, the Commission has publisheed a progress report on medicines for children covering the five years since the Paediatric Regulation came into force. This preliminary snapshot points to improvements in...

New symbol to identify medicines undergoing additional monitoring

News image

An inverted triangle will shortly appear on the inside leaflet of certain medicinal products on the EU market, following a legal act adopted by the European Commission today. The symbol...

Launch of EU Rapid Alert platform for human Tissues and Cells

News image

A secure alert platform launched by the European Commission will improve the safety of patients undergoing transplantation and medical procedures involving human tissues and cells, e.g. bone marrow, cornea, skin,...

Commission proposes faster access to medicines for patients

News image

Medicines should enter the market faster. With this intention the European Commission has proposed today to streamline and reduce the duration of national decisions on pricing and reimbursement of medicines....

Pricing and reimbursement of medicines: Commission consults on EU transparency rules

News image

The European Commission has launched a public consultation in view of modernising rules on the transparency of Member States’ decisions regarding the pricing and reimbursement of medicines. The consultation invites...

More in: European Commission

EMA News

Committee for orphan medicines - overview of 2013 and looking ahead

News image

A total of 11 out of 81 medicines recommended for marketing authorisation by the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) in 2013 were intended...

PRAC recommends suspending use of Protelos/Osseor

News image

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) has recommended that Protelos/Osseor should no longer be used to treat osteoporosis. In April 2013 the Agency had recommended restricting the...

EMA and US FDA release first conclusions of parallel assessment of quality-by-design applications

News image

The European Medicines Agency (EMA) and the United States Food and Drug Administration (US FDA) have published a joint question-and-answer document that outlines the conclusions of their first parallel...

European Medicines Agency creates Healthcare Professionals' Working Party

News image

The European Medicines Agency has established a formal Healthcare Professionals’ Working Party (HCPWP) to further involve this group of stakeholders in its range of activities. The role of the HCPWP...

More in: EMA